MedinCell S.A.

Symbol: MDCLF

PNK

6.9757

USD

Market price today

  • -6.9104

    P/E Ratio

  • 0.2725

    PEG Ratio

  • 200.11M

    MRK Cap

  • 0.00%

    DIV Yield

MedinCell S.A. (MDCLF) Financial Statements

On the chart you can see the default numbers in dynamics for MedinCell S.A. (MDCLF). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of MedinCell S.A., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016

balance-sheet.row.cash-and-short-term-investments

74.036.526.649.9
12.4
21.3
8.8
8.3
2.5

balance-sheet.row.short-term-investments

19.55022.8
0.3
0.1
0
4.5
1.9

balance-sheet.row.net-receivables

29.3712.35.74.6
4.4
3.3
3.5
4.8
0

balance-sheet.row.inventory

1.550.81.81.8
0.9
1.3
1.3
0.8
0

balance-sheet.row.other-current-assets

1.760.100
0.1
0
0
0.1
0.1

balance-sheet.row.total-current-assets

114.1619.634.156.3
17.7
26
13.6
14
7.1

balance-sheet.row.property-plant-equipment-net

25.846.473.9
4.1
3.3
2.7
2.5
1.5

balance-sheet.row.goodwill

0000
0
0
0
0
0

balance-sheet.row.intangible-assets

7.381.91.71.5
1.5
1.4
2
1.6
1.3

balance-sheet.row.goodwill-and-intangible-assets

7.381.91.71.5
1.5
1.4
2
1.6
1.3

balance-sheet.row.long-term-investments

-3.430.5-1.8-2.4
2.1
2.5
1.6
-2
-1.9

balance-sheet.row.tax-assets

5.13-0.504.4
1.9
2.5
2.5
2.7
1.2

balance-sheet.row.other-non-current-assets

7.821.53.40
0
2.2
2.9
4.6
3.9

balance-sheet.row.total-non-current-assets

42.749.810.27.3
9.6
12
11.7
9.3
4.1

balance-sheet.row.other-assets

0000
0
0
0
0
0

balance-sheet.row.total-assets

156.9129.344.363.6
27.3
38
25.4
23.3
11.2

balance-sheet.row.account-payables

12.974.233
3.2
1.6
2.4
2.1
1.6

balance-sheet.row.short-term-debt

89.3343.528.33.6
1.8
3.4
2.3
0.8
1.7

balance-sheet.row.tax-payables

2.740.60.10.1
0.1
0.1
0.2
0.1
0.1

balance-sheet.row.long-term-debt-total

125.214.319.139.8
32.1
23.6
28.7
19.9
2.6

Deferred Revenue Non Current

0000.8
4.1
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-

balance-sheet.row.other-current-liab

4.160.10.10.2
0.1
0
0.2
2.5
3.8

balance-sheet.row.total-non-current-liabilities

131.7514.619.441.1
36.7
24
29
20.1
2.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

12.383.23.51.1
1.1
0.2
0.2
0
0

balance-sheet.row.total-liab

264.3971.657.754.7
43.3
31.7
37.1
25.6
9.8

balance-sheet.row.preferred-stock

91.075020.566.3
49.3
0.1
0
0
0

balance-sheet.row.common-stock

1.040.30.30.2
0.2
0.2
0.1
0.1
0.1

balance-sheet.row.retained-earnings

-78.72-32-24.8-19
-23.9
-19.7
-9.6
-3.6
0.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

-140.21-50-20.5-66.3
-49.3
-0.1
0
0
0

balance-sheet.row.other-total-stockholders-equity

19.34-10.511.227.7
7.8
25.7
-2.4
1.1
0.5

balance-sheet.row.total-stockholders-equity

-107.48-42.3-13.48.9
-16
6.2
-11.8
-2.3
1.2

balance-sheet.row.total-liabilities-and-stockholders-equity

156.9129.344.363.6
27.3
38
25.4
23.3
11.2

balance-sheet.row.minority-interest

0000
0
0
0
0
0.1

balance-sheet.row.total-equity

-107.48-42.3-13.48.9
-16
6.2
-11.7
-
-

balance-sheet.row.total-liabilities-and-total-equity

156.91---
-
-
-
-
-

Total Investments

16.120.50.10.3
2.4
2.5
1.7
2.5
0

balance-sheet.row.total-debt

216.8757.747.543.3
33.8
27
31
20.7
4.3

balance-sheet.row.net-debt

162.3951.222.9-3.8
21.5
5.8
22.2
16.9
3.7

Cash Flow Statement

The financial landscape of MedinCell S.A. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016

cash-flows.row.net-income

-53.22-32-24.8-19
-23.9
-19.7
-9.6
-3.5
0.6

cash-flows.row.depreciation-and-amortization

3.331.71.51.3
1.3
0.8
0.7
0.6
0.3

cash-flows.row.deferred-income-tax

010.10.1
2.7
-0.4
0.9
-1
-0.1

cash-flows.row.stock-based-compensation

02.32.41.6
1.7
0.1
0.1
0
0.1

cash-flows.row.change-in-working-capital

-8.96-3-2.40.6
3.6
-1
0.8
-1.4
-0.9

cash-flows.row.account-receivables

-6.43-5.8-1.4-1.2
-1
-1.4
0
0
0

cash-flows.row.inventory

0000
0
0.1
-0.7
-0.8
0

cash-flows.row.account-payables

-0.061.20-0.2
1.5
0.4
0
0
0

cash-flows.row.other-working-capital

-2.461.6-12
3.1
0
1.5
-0.7
0

cash-flows.row.other-non-cash-items

9.659.11.83.2
2.2
4.3
1.7
1
0

cash-flows.row.net-cash-provided-by-operating-activities

-49.2000
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-2.73-1-2-0.8
-0.9
-0.8
-1.2
-1.8
-1.2

cash-flows.row.acquisitions-net

0000
-0.6
-0.1
0
0
0

cash-flows.row.purchases-of-investments

-0.33-0.3-1.2-0.3
0
-0.1
0
0
0

cash-flows.row.sales-maturities-of-investments

3.252.61.50
0.9
0.6
0
0
0

cash-flows.row.other-investing-activites

001.30
0.7
-0.6
3.4
-6.5
-0.7

cash-flows.row.net-cash-used-for-investing-activites

0.21.3-0.3-1.1
0.1
-0.8
2.2
-7.9
-1.5

cash-flows.row.debt-repayment

-21.77-24.1-2.3-9.3
-3.1
-2.4
-2.6
-3.1
-0.4

cash-flows.row.common-stock-issued

24.10.8042.3
0
22.8
0
0
0

cash-flows.row.common-stock-repurchased

-0.250-0.20
0
-0.1
0
0
0

cash-flows.row.dividends-paid

-4.21000
-6.6
0
0
-17.8
0

cash-flows.row.other-financing-activites

7.1624.91.714.9
13.2
8.9
10.8
17.8
1

cash-flows.row.net-cash-used-provided-by-financing-activities

41.381.6-0.847.9
3.6
29.2
8.2
14.6
0.6

cash-flows.row.effect-of-forex-changes-on-cash

-12.11000
0
0
0
-0.2
0

cash-flows.row.net-change-in-cash

-19.73-18.1-22.534.7
-8.9
12.5
5
3.2
-0.9

cash-flows.row.cash-at-end-of-period

44.486.524.647.1
12.4
21.3
8.8
3.8
0.6

cash-flows.row.cash-at-beginning-of-period

64.224.647.112.4
21.3
8.8
3.8
0.6
1.5

cash-flows.row.operating-cash-flow

-49.2-21-21.4-12.1
-12.5
-15.9
-5.4
-3.4
0.1

cash-flows.row.capital-expenditure

-2.73-1-2-0.8
-0.9
-0.8
-1.2
-1.8
-1.2

cash-flows.row.free-cash-flow

-51.92-22-23.3-13
-13.5
-16.7
-6.6
-5.2
-1.1

Income Statement Row

MedinCell S.A.'s revenue saw a change of NaN% compared with the previous period. The gross profit of MDCLF is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016

income-statement-row.row.total-revenue

19.369.94.18.2
2.9
1.4
6.4
8.5
8.2

income-statement-row.row.cost-of-revenue

0001.5
1
1
0.2
0.9
0

income-statement-row.row.gross-profit

19.369.94.16.7
1.9
0.4
6.2
7.6
8.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0

income-statement-row.row.research-development

48.98---
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-

income-statement-row.row.other-expenses

0000
-0.1
0
0
0
0

income-statement-row.row.operating-expenses

68.413427.922.3
22.1
15.9
13.5
10.4
7.8

income-statement-row.row.cost-and-expenses

71.743427.923.8
22.1
17
13.7
11.3
7.8

income-statement-row.row.interest-income

0.2000
0.1
0
0.1
0
0

income-statement-row.row.interest-expense

7.33.91.82.3
2.1
2.1
1.8
1.3
0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-7.56-8-1-3.4
-2.1
-4.2
-1.8
-1.3
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
-0.1
0
0
0
0

income-statement-row.row.total-operating-expenses

-7.56-8-1-3.4
-2.1
-4.2
-1.8
-1.3
-0.1

income-statement-row.row.interest-expense

7.33.91.82.3
2.1
2.1
1.8
1.3
0.1

income-statement-row.row.depreciation-and-amortization

3.331.71.51.3
1.3
0.8
0.7
0.6
0.3

income-statement-row.row.ebitda-caps

-49.05---
-
-
-
-
-

income-statement-row.row.operating-income

-52.38-24-23.8-15.6
-19.3
-15.5
-7.4
-3.6
0.4

income-statement-row.row.income-before-tax

-59.94-32-24.8-19
-21.4
-19.7
-9.2
-4.9
0.3

income-statement-row.row.income-tax-expense

-6.72-40.9-1.4
2.5
0
0.4
-1.4
-0.3

income-statement-row.row.net-income

-53.22-32-24.8-19
-23.9
-19.7
-9.6
-3.6
0.6

Frequently Asked Question

What is MedinCell S.A. (MDCLF) total assets?

MedinCell S.A. (MDCLF) total assets is 29339000.000.

What is enterprise annual revenue?

The annual revenue is 10847000.000.

What is firm profit margin?

Firm profit margin is 1.000.

What is company free cash flow?

The free cash flow is -1.031.

What is enterprise net profit margin?

The net profit margin is -2.436.

What is firm total revenue?

The total revenue is -2.272.

What is MedinCell S.A. (MDCLF) net profit (net income)?

The net profit (net income) is -32010000.000.

What is firm total debt?

The total debt is 57708000.000.

What is operating expences number?

The operating expences are 33989000.000.

What is company cash figure?

Enretprise cash is 11667000.000.